{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T17:19:55Z","timestamp":1770743995582,"version":"3.49.0"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"Supplement_E","license":[{"start":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T00:00:00Z","timestamp":1633910400000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Heart Association of Trieste"},{"name":"Tonolli Verbania Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The pressure overload due to the progressive narrowing of the valve area determines the development of the left ventricular hypertrophy which characterizes aortic stenosis (AS). The onset of myocardial fibrosis marks the inexorable decline of an initially compensatory response towards heart failure. However, myocardial fibrosis does not yet represent a key element in the prognostic and therapeutic framework of AS. In this context, cardiac magnetic resonance imaging plays a major role by highlighting both the focal irreversible fibrotic replacement, using the late gadolinium enhancement (LGE) technique, and the earlier diffuse reversible interstitial fibrosis, using the T1 mapping techniques. For this reason, the presence of myocardial fibrosis would be useful to identify a subgroup of patients at greater risk of events among the subjects with severe AS. Actually, more and more evidences seem to identify the presence of LGE as a powerful prognostic factor to be used to optimize the timing of prosthetic valve replacement. Randomized clinical trials, such as the EVoLVeD trial currently underway, will be needed to better define the importance of myocardial fibrosis assessment in the management of patients with AS.<\/jats:p>","DOI":"10.1093\/eurheartj\/suab120","type":"journal-article","created":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T08:12:27Z","timestamp":1633939947000},"page":"E147-E150","source":"Crossref","is-referenced-by-count":11,"title":["Clinical impact of myocardial fibrosis in severe aortic stenosis"],"prefix":"10.1093","volume":"23","author":[{"given":"Matteo","family":"Castrichini","sequence":"first","affiliation":[{"name":"Division of Cardiology, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), Trieste, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giancarlo","family":"Vitrella","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), Trieste, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"De Luca","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), Trieste, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Altinier","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), Trieste, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata","family":"Korcova","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), Trieste, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Pagura","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), Trieste, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cinzia","family":"Radesich","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), Trieste, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianfranco","family":"Sinagra","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), Trieste, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,10,8]]},"reference":[{"key":"2021101106040622600_suab120-B1","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/ehjci\/jeaa009","article-title":"The evaluation of aortic stenosis, how the new guidelines are implemented across Europe: a survey by EACVI","volume":"21","author":"Michalski","year":"2020","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2021101106040622600_suab120-B2","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jacc.2009.12.074","article-title":"Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease","volume":"56","author":"Azevedo","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2021101106040622600_suab120-B3","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.jacc.2011.03.064","article-title":"Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis","volume":"58","author":"Dweck","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2021101106040622600_suab120-B4","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jacc.2014.02.612","article-title":"Prognostic significance of LGE by CMR in aortic stenosis patients undergoing valve replacement","volume":"64","author":"Barone-Rochette","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2021101106040622600_suab120-B5","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(09)60211-7","article-title":"Aortic stenosis","volume":"373","author":"Carabello","year":"2009","journal-title":"Lancet"},{"key":"2021101106040622600_suab120-B6","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/hrt.2005.074112","article-title":"The left ventricle in aortic stenosis: evidence for the use of ACE inhibitors","volume":"92","author":"Chambers","year":"2005","journal-title":"Heart"},{"key":"2021101106040622600_suab120-B7","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1161\/01.CIR.79.4.744","article-title":"Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement","volume":"79","author":"Krayenbuehl","year":"1989","journal-title":"Circulation"},{"key":"2021101106040622600_suab120-B8","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jacc.2017.12.035","article-title":"Reverse myocardial remodeling following valve replacement in patients with aortic stenosis","volume":"71","author":"Treibel","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2021101106040622600_suab120-B9","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/eurheartj\/ehx353","article-title":"Reappraising myocardial fibrosis in severe aortic stenosis: an invasive and non-invasive study in 133 patients","volume":"39","author":"Treibel","year":"2018","journal-title":"Eur Heart J"},{"key":"2021101106040622600_suab120-B10","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1093\/eurheartj\/ehaa033","article-title":"Impact of myocardial fibrosis on left ventricular remodelling, recovery, and outcome after transcatheter aortic valve implantation in different haemodynamic subtypes of severe aortic stenosis","volume":"41","author":"Puls","year":"2020","journal-title":"Eur Heart J"},{"key":"2021101106040622600_suab120-B11","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jcmg.2018.11.026","article-title":"Imaging and impact of myocardial fibrosis in aortic stenosis","volume":"12","author":"Bing","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"2021101106040622600_suab120-B12","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1161\/CIRCULATIONAHA.108.847772","article-title":"Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis","volume":"120","author":"Weidemann","year":"2009","journal-title":"Circulation"},{"key":"2021101106040622600_suab120-B13","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1161\/CIRCULATIONAHA.117.032839","article-title":"Myocardial scar and mortality in severe aortic stenosis: data from the BSCMR Valve Consortium","volume":"138","author":"Musa","year":"2018","journal-title":"Circulation"},{"key":"2021101106040622600_suab120-B14","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jcmg.2019.03.029","article-title":"The prognostic role of late gadolinium enhancement in aortic stenosis","volume":"13","author":"Papanastasiou","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"2021101106040622600_suab120-B15","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jcmg.2019.01.036","article-title":"Management of asymptomatic severe aortic stenosis","volume":"13","author":"Lindman","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"2021101106040622600_suab120-B16","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","article-title":"2017 ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"38","author":"Baumgartner","year":"2017","journal-title":"Eur Heart J"},{"key":"2021101106040622600_suab120-B17","first-page":"e72","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"key":"2021101106040622600_suab120-B18","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.jcmg.2017.09.005","article-title":"Noncontrast myocardial T1 mapping by cardiac magnetic resonance predicts outcome in patients with aortic stenosis","volume":"11","author":"Lee","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"2021101106040622600_suab120-B19","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/ehjci\/jez201","article-title":"Aortic valve replacement-induced changes in native T1 are related to prognosis in severe aortic stenosis: T1 mapping cardiac magnetic resonance imaging study","volume":"21","author":"Hwang","year":"2020","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2021101106040622600_suab120-B20","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jacc.2019.11.032","article-title":"Extracellular myocardial volume in patients with aortic stenosis","volume":"75","author":"Everett","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2021101106040622600_suab120-B21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ahj.2019.02.018","article-title":"Rationale and design of the randomized, controlled Early Valve Replacement Guided by Biomarkers of Left Ventricular Decompensation in Asymptomatic Patients with Severe Aortic Stenosis (EVOLVED) trial","volume":"212","author":"Bing","year":"2019","journal-title":"Am Heart J"}],"container-title":["European Heart Journal Supplements"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartjsupp\/article-pdf\/23\/Supplement_E\/E147\/40544802\/suab120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/eurheartjsupp\/article-pdf\/23\/Supplement_E\/E147\/40544802\/suab120.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T08:12:59Z","timestamp":1633939979000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article\/23\/Supplement_E\/E147\/6386366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,1]]},"references-count":21,"journal-issue":{"issue":"Supplement_E","published-online":{"date-parts":[[2021,10,8]]},"published-print":{"date-parts":[[2021,10,9]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/suab120","relation":{},"ISSN":["1520-765X","1554-2815"],"issn-type":[{"value":"1520-765X","type":"print"},{"value":"1554-2815","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,10,1]]},"published":{"date-parts":[[2021,10,1]]}}}